Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06829498 · ClinicalTrials.gov registry record · Phase 2

BCAAs in Concussion 2.0

A Phase 2 study of Concussion, Brain and Concussion, Mild, sponsored by Akiva Cohen.

Recruiting
Registry status
Phase 2
Development phase
150
Enrollment target
1
Study location

NCT06829498 is a Phase 2 study of Concussion, Brain and Concussion, Mild that is actively recruiting participants, run by Akiva Cohen. The registered enrollment target is 150 participants, below the 177-participant average among 20 other Concussion, Brain trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06829498, a Phase 2 study of Concussion, Brain and Concussion, Mild, is actively recruiting participants, sponsored by Akiva Cohen.

RECRUITING
Registry status
Phase 2
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.

Interventions

  • OTHER Placebo
  • DRUG BCAA

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-04-01
Est. Completion 2026-08
Phase Phase 2

Sponsor

Akiva Cohen

1 total trials

What the Registry Record Tells You About NCT06829498

The ClinicalTrials.gov registry entry for NCT06829498 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 20 other Concussion, Brain trials with a reported enrollment target (15% lower). The listed sponsor is Akiva Cohen, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Concussion, Brain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06829498 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06829498 about?

NCT06829498 is a clinical study titled "BCAAs in Concussion 2.0". This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery...

What is the current status of trial NCT06829498?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2026-08.

What conditions does trial NCT06829498 study?

This clinical trial studies the following conditions: Concussion, Brain, Concussion, Mild, Concussion.

What interventions are being tested in trial NCT06829498?

The interventions under investigation include: Placebo (OTHER), BCAA (DRUG).

Who is sponsoring clinical trial NCT06829498?

This trial is sponsored by Akiva Cohen, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06829498 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion, Brain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.